A joint analysis group—led by Professor Younger Seok Cho from the College of Medication, alongside Professor James J. Moon from the College of Michigan—has efficiently developed the world’s first oral, microbiome-based nanomedicine. By leveraging pure metabolites produced by intestine micro organism, the brand new drug considerably enhances the flexibility of immune cells to assault most cancers cells. This breakthrough research was printed within the newest concern of Nature Nanotechnology, one of many world’s premier journals in nanoscience and drugs.
Lately, “immunotherapy” (reminiscent of anti-PD-1 medicine) has emerged as a revolutionary therapy choice that reawakens the physique’s personal immune system to battle most cancers. Nevertheless, its effectiveness has been restricted as a result of solely a small fraction of sufferers reply positively. To beat this problem, the analysis group targeted on the connection between intestine microbiome and immunity. They found {that a} microbial metabolite referred to as 3,4-dihydroxybenzoic acid (DHB) acts as a strong immune booster, safely driving the physique’s defenses towards tumors.
The research revealed that DHB strongly promotes “stemness” in CD8+ T cells—the first immune cells liable for destroying most cancers. Usually, T cells grow to be exhausted and lose their preventing energy on account of overactive sugar breakdown processes (glycolysis). DHB blocks this metabolic exhaustion and activates a survival change, enabling T cells to remain energetic and assault most cancers cells over longer durations.
Regardless of its promise, pure DHB introduced a serious impediment: as soon as ingested, it quickly breaks down and disappears from the physique inside minutes. To unravel this, the group utilized superior nanotechnology. They chemically modified DHB right into a secure prodrug and additional encapsulated it into an oleic acid-based oral nano-emulsion (named Prodrug 201).
This oral nanomedicine drastically extends the time the drug stays within the bloodstream, boosting its total absorption price (bioavailability) by 14.3 occasions. In animal fashions with colorectal most cancers, melanoma, and breast most cancers, the oral nanomedicine successfully directed refreshed, stem-like T cells proper into the tumor websites, resulting in dramatic tumor shrinkage. When mixed with immune checkpoint blockade remedy, it utterly eradicated tumors in check fashions and created long-term immune reminiscence to forestall most cancers recurrence.
“This research unveils the molecular secret of how intestine microbial metabolite regulate our immune system and efficiently interprets that data right into a handy, oral remedy by nanotechnology,” stated Professor Younger Seok Cho, who led the analysis. “By changing beforehand untapped microbial sources right into a protected and scalable nanomedicine, this work builds a essential basis for commercializing next-generation microbiome-based most cancers immunotherapies.”
